A new haematocytometric index: Predicting severity and mortality risk value in COVID-19 patients.

ABSTRACT:

Introduction

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 virus, is a major public health concern spanning from healthy carriers to patients with life-threatening conditions. Although most of COVID-19 patients have mild-to-moderate clinical symptoms, some patients have severe pneumonia leading to death. Therefore, the early prediction of disease prognosis and severity is crucial in COVID-19 patients. The main objective of this study is to evaluate the haemocytometric parameters and identify severity score associated with SARS-CoV-2 infection.

Methods

Clinical and laboratory records were retrospectively reviewed from 97 cases of COVID-19 admitted to hospitals in Istanbul, Turkey. The patient groups were subdivided into three major groups: Group 1 (Non-critical): 5

SUBMITTER: Kilercik M 

PROVIDER: S-EPMC8341498 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature